Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company’s commitment to advancing lateral surgery will be prominent at the 2023 NASS Annual Meeting. The Company will introduce the Calibrate LTXTM lateral expandable implant system, technology designed to better achieve alignment goals with precise lordosis control and disc height restoration.
“ATEC is uniquely dedicated to improving lateral surgery,” said Pat Miles, Chairman and Chief Executive Officer. “The release of Calibrate LTX elevates our lateral procedural thesis by better enabling surgeons to achieve the most elusive goal of surgery: alignment. When it comes to alignment, EOS is the best imaging tool to determine it, PTPTM is the best lateral procedure to achieve it and Calibrate LTX is the expandable implant system that best drives it. At NASS, we will demonstrate how to apply PTP in increasingly complex procedures and how to employ LTPTM to address L3 through S1, the most commonly treated levels in spine. Our path to becoming the standard bearer in lateral surgery will be apparent.”
Anthony Kwon, M.D., Orthopedic Spine Surgeon at OrthoCarolina and Atrium Medical Center in Charlotte, NC, added, "The Calibrate LTX expandable lateral system seamlessly integrates with ATEC's entire lateral platform. The simplicity and ease of insertion of the implant is unique compared to the over-engineering that plagues other expandable systems. Enhanced visibility, powerful expansion and ease of back-filling make LTX the ideal expandable interbody solution."
Innovation Update for Investors
Calibrate LTX will be a feature of a technology-focused meeting for investors on October 18, 2023, from 7:30am to 9:00am PT at the JW Marriott Los Angeles. RSVP here if you plan to join the event in person. A webcast will be also available for those unable to attend. To access the webcast, please visit the Investor Relations Section of ATEC’s Corporate Website.
Booth Presentations
ATEC is partnering with renowned spine surgeons to demonstrate how ATEC innovation can improve clinical precision and predictability. Visit ATEC booth #1801 to view the following presentations:
Presentation |
Date |
Time (PT) |
Presenter |
PTPTM: The Evolution of the Lateral Approach |
10/18 |
9:10am |
Luiz Pimenta, MD, PhD William Taylor, MD |
Informing Better Spine Surgery with Precision Technology |
10/18 |
12:00pm |
Juan Uribe, MD Kevin Foley, MD |
Streamlined Single Position Anterior Column Approaches |
10/18 |
3:00pm |
Hardeep Singh, MD |
EOS: Standardizing Care with End-To-End Solutions |
10/19 |
9:35am |
Vedat Deviren, MD |
Achieving Sagittal Alignment with PTPTM and CalibrateTM LTX |
10/19 |
12:00pm |
Vedat Deviren, MD Srikanth N. Divi, MD |
Reducing Mechanical Complications in Adult Spinal Deformity: Invictus® Fenestrated and S.I. Core |
10/19 |
3:00pm |
Jay Turner, MD |
About ATEC
ATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC’s Organic Innovation MachineTM is focused on developing new approaches that integrate seamlessly with the Company’s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC’s vision is to be the Standard Bearer in Spine. For more information, visit us at www.atecspine.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described therein. Forward-looking statements include references to the Company’s expectations with respect to future revenue and growth and planned commercial launches, introductions, integration, regulatory submissions or clearances. The important factors that could cause actual operating results to differ significantly from those expressed or implied by such forward-looking statements include, but are not limited to: failure to achieve acceptance of the Company’s products by the surgeon community and the uncertainty of success in developing new products or products currently in the pipeline. The words “believe,” “will,” “should,” “expect,” “intend,” “estimate,” “look forward” and “anticipate,” and variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. A further list and description of these and other factors, risks and uncertainties can be found in the Company's most recent annual report, and any subsequent quarterly and current reports, filed with the Securities and Exchange Commission. ATEC disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231016459805/en/
Contacts
Investor/Media Contact:
Tina Jacobsen, CFA
Investor Relations
(760) 494-6790
investorrelations@atecspine.com
Company Contact:
J. Todd Koning
Chief Financial Officer
Alphatec Holdings, Inc.
investorrelations@atecspine.com
